Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Major analysis of the non-invasive treatment of obstructive sleep apnea initiated in Denmark

On November 25, 2022, the Treatment Council (Behandlingsråd) announced the third topic selected for major analyses (større analyser) for 2023.

The selected topic is regarding the non-invasive treatment of obstructive sleep apnea. This topic was nominated in the spring by Rigshospitalet and Gødstrup Regional Hospital, and it was subsequently adjusted after dialogue between clinical environments and the Secretariat of the Treatment Council. The final subject area for the analysis will be determined by the future specialist committee and submitted to the Treatment Council for approval. The Secretariat of the Treatment Council has started work and is expected to make a recommendation in early 2024.

The Treatment Council announced another two topics selected for major analyses for 2023 earlier in October 2022; these included the use of home non-invasive ventilation and the use of internet-based cognitive behavioral therapy.

The Treatment Council is a new body for the procedure and technologies evaluation that became fully operational in late May 2021. The Treatment Council is expected to prepare 2-3 major annual analyses based on the fundamental topics concerning the treatment regimens or treatment organization approaches. Based on the received proposals, the Board of the Danish Regions selects 2-3 analysis topics once a year, which constitutes the Council's annual program for major analyses.

The full details in Danish can be found here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts” and “Reimbursement Alerts” every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news).

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks). First EU issues of both newsletters are available for download free-of-charge.